WATSON PHARMACEUTICALS INC 4
4 · WATSON PHARMACEUTICALS INC · Filed May 16, 2008
Insider Transaction Report
Form 4
HSIA DAVID C
Sr. VP, Scientific Affairs
Transactions
- Sale
Common Stock, par value $0.0033
2008-05-15$28.65/sh−50,000$1,432,415→ 642,085 total(indirect: By Trust)
Holdings
- 89,428
Common Stock, par value $0.0033
- 40,000(indirect: By Trust)
Common Stock, par value $0.0033
Footnotes (3)
- [F1]Includes shares of restricted stock issued pursuant to the Second Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.
- [F2]By Family Trust refers to the Hsia Family Trust, of which Dr. Hsia is a beneficial owner.
- [F3]By Partnership refers to the Hsia Interests, Ltd., of which Dr. Hsia is a general partner.